Igovomab | m-entrepreneurship.com

Product Name :
Igovomab

Search keywords :
Igovomab

drugId :
null

Target Vo:
Mucin-16

Target Vo Short Name :
MUC16

Moa_Name:
Immunomodulators

First Approval Country :
EU

First Approval Date Filter:
1996

Origin Company_Name :
Cis Bio International Sa

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Ovarian Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Withdrawn

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
GAPDH Antibody (HRP) (YA874)
JunB Antibody
Mucin 5B Antibody: Mucin 5B Antibody is an unconjugated, mouse-derived, anti-Mucin 5B monoclonal antibody. Mucin 5B Antibody can be used for: IHC-P, FC, ELISA expriments in human background without labeling.

Author: Betaine hydrochloride

Related Posts